| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phospholipid transfer activity | 3.52e-05 | 26 | 145 | 4 | GO:0120014 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 5.82e-05 | 57 | 145 | 5 | GO:0120013 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX19A ATP8B4 ERCC3 KIF1A MYO9B WRN HELQ MOV10L1 MACF1 HFM1 CHD6 ATP1A4 | 9.27e-05 | 441 | 145 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | helicase activity | 1.58e-04 | 158 | 145 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 1.96e-04 | 16 | 145 | 3 | GO:0043138 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.74e-04 | 229 | 145 | 8 | GO:0140993 | |
| GeneOntologyMolecularFunction | Y-form DNA binding | 3.11e-04 | 4 | 145 | 2 | GO:0000403 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.32e-04 | 127 | 145 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 3.91e-04 | 20 | 145 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19A ATP8B4 ERCC3 KIF1A MYO9B WRN HELQ BPTF MOV10L1 MACF1 HFM1 CHD6 ATP1A4 | 5.48e-04 | 614 | 145 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | lipid transporter activity | 5.82e-04 | 196 | 145 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 6.82e-04 | 55 | 145 | 4 | GO:0042974 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 7.81e-04 | 206 | 145 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.01e-03 | 279 | 145 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 1.07e-03 | 62 | 145 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | ceramide 1-phosphate binding | 1.07e-03 | 7 | 145 | 2 | GO:1902387 | |
| GeneOntologyMolecularFunction | ceramide 1-phosphate transfer activity | 1.07e-03 | 7 | 145 | 2 | GO:1902388 | |
| GeneOntologyMolecularFunction | ceramide transfer activity | 1.42e-03 | 8 | 145 | 2 | GO:0120017 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.42e-03 | 8 | 145 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.78e-03 | 71 | 145 | 4 | GO:0042054 | |
| GeneOntologyMolecularFunction | sphingolipid transfer activity | 1.82e-03 | 9 | 145 | 2 | GO:0120016 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 2.07e-03 | 74 | 145 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.25e-03 | 36 | 145 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 2.27e-03 | 10 | 145 | 2 | GO:0140031 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.27e-03 | 10 | 145 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 2.27e-03 | 10 | 145 | 2 | GO:0045322 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 8.31e-06 | 20 | 137 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.34e-05 | 9 | 137 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 3.32e-05 | 10 | 137 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | UIMC1 SETD1B NSD2 KDM6B BPTF BRCA1 MOV10L1 CFDP1 NFRKB KDM2B NCOA1 KMT2A CHD6 SUZ12 HCFC2 LRIF1 | 3.39e-05 | 741 | 137 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | HIF1A AHI1 ANK3 MYOM1 NSD2 MYRIP SRCIN1 RAB11FIP1 ABLIM3 CHRM3 C2CD2L BRCA1 KCNB1 SYT4 CEP295 | 4.30e-05 | 674 | 137 | 15 | GO:0070201 |
| GeneOntologyBiologicalProcess | intermembrane lipid transfer | 7.40e-05 | 34 | 137 | 4 | GO:0120009 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 7.81e-05 | 13 | 137 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 9.89e-05 | 14 | 137 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | regulation of protein secretion | HIF1A AHI1 MYOM1 MYRIP SRCIN1 RAB11FIP1 CHRM3 C2CD2L KCNB1 SYT4 | 1.19e-04 | 350 | 137 | 10 | GO:0050708 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | UIMC1 RGPD2 HIF1A ERCC3 MIS18BP1 SETD1B AFF2 RGPD8 CDK12 ICE2 RGPD1 ARFGEF1 MED1 KDM6B BPTF BRCA1 CFDP1 NFRKB KDM2B NCOA1 KMT2A BOD1L1 SUZ12 HCFC2 AFF4 RGPD5 | 2.70e-06 | 1377 | 145 | 26 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear inclusion body | 9.87e-06 | 20 | 145 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.04e-05 | 108 | 145 | 7 | GO:0034708 | |
| GeneOntologyCellularComponent | transferase complex | RGPD2 RAD18 ERCC3 SETD1B RGPD8 PSG4 CDK12 WWP1 ZC3H13 RGPD1 REV3L MED1 KDM6B BRCA1 KMT2A BOD1L1 HADHA SUZ12 HCFC2 SMCR8 | 1.14e-05 | 963 | 145 | 20 | GO:1990234 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 1.36e-05 | 75 | 145 | 6 | GO:0035097 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.78e-05 | 8 | 145 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.79e-05 | 10 | 145 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | nuclear body | UIMC1 ZC3H14 HIF1A RAD18 SETD1B AFF2 CDK12 ICE2 ZC3H13 WRN ANKS1B CMYA5 SKIL ERBIN BRCA1 ZNF638 SUZ12 HCFC2 | 5.52e-05 | 903 | 145 | 18 | GO:0016604 |
| GeneOntologyCellularComponent | annulate lamellae | 1.13e-04 | 14 | 145 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | Set1C/COMPASS complex | 1.71e-04 | 16 | 145 | 3 | GO:0048188 | |
| GeneOntologyCellularComponent | sex chromosome | 2.43e-04 | 44 | 145 | 4 | GO:0000803 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.47e-04 | 18 | 145 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD2 SLK ANK2 RGPD8 KIF1A MYO9B RGPD1 MYRIP ARFGEF1 CMYA5 SYAP1 BPTF P2RX4 KCNB1 CD34 SYT4 RAPGEF2 | 2.65e-04 | 934 | 145 | 17 | GO:0048471 |
| GeneOntologyCellularComponent | SUMO ligase complex | 3.97e-04 | 21 | 145 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | costamere | 4.57e-04 | 22 | 145 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 6.17e-04 | 56 | 145 | 4 | GO:0008023 | |
| GeneOntologyCellularComponent | neuronal dense core vesicle membrane | 7.04e-04 | 6 | 145 | 2 | GO:0099012 | |
| GeneOntologyCellularComponent | super elongation complex | 7.04e-04 | 6 | 145 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | postsynapse | ANK2 ANK3 KIF1A MYO9B ANKS1B SRCIN1 GABBR2 SYAP1 ERBIN CHRM3 P2RX4 KCNB1 NETO1 MACF1 SYT4 RAPGEF2 SMCR8 | 7.06e-04 | 1018 | 145 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | nuclear speck | ZC3H14 HIF1A SETD1B AFF2 CDK12 ZC3H13 WRN CMYA5 ERBIN ZNF638 | 8.70e-04 | 431 | 145 | 10 | GO:0016607 |
| GeneOntologyCellularComponent | M band | 1.27e-03 | 31 | 145 | 3 | GO:0031430 | |
| GeneOntologyCellularComponent | axon cytoplasm | 1.28e-03 | 68 | 145 | 4 | GO:1904115 | |
| GeneOntologyCellularComponent | BRCA1-A complex | 1.30e-03 | 8 | 145 | 2 | GO:0070531 | |
| GeneOntologyCellularComponent | dense core granule membrane | 2.07e-03 | 10 | 145 | 2 | GO:0032127 | |
| Domain | Grip | 1.04e-06 | 11 | 143 | 4 | SM00755 | |
| Domain | GRIP | 1.04e-06 | 11 | 143 | 4 | PF01465 | |
| Domain | Ran_BP1 | 1.56e-06 | 12 | 143 | 4 | PF00638 | |
| Domain | RANBD1 | 1.56e-06 | 12 | 143 | 4 | PS50196 | |
| Domain | GRIP_dom | 1.56e-06 | 12 | 143 | 4 | IPR000237 | |
| Domain | GRIP | 1.56e-06 | 12 | 143 | 4 | PS50913 | |
| Domain | RanBD | 2.23e-06 | 13 | 143 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 2.23e-06 | 13 | 143 | 4 | IPR000156 | |
| Domain | Rab_bind | 1.50e-05 | 7 | 143 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.50e-05 | 7 | 143 | 3 | IPR032023 | |
| Domain | - | 5.07e-05 | 10 | 143 | 3 | 1.10.220.60 | |
| Domain | ANK_REPEAT | ANK2 ANK3 ANKS1B MUC16 ANKRD30B ANKHD1 ANKRD36B ANKRD36 ANKFN1 | 1.47e-04 | 253 | 143 | 9 | PS50088 |
| Domain | ANK_REP_REGION | ANK2 ANK3 ANKS1B MUC16 ANKRD30B ANKHD1 ANKRD36B ANKRD36 ANKFN1 | 1.51e-04 | 254 | 143 | 9 | PS50297 |
| Domain | Helicase_C | 1.74e-04 | 107 | 143 | 6 | PF00271 | |
| Domain | HELICc | 1.74e-04 | 107 | 143 | 6 | SM00490 | |
| Domain | Helicase_C | 1.83e-04 | 108 | 143 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 1.92e-04 | 109 | 143 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.92e-04 | 109 | 143 | 6 | PS51192 | |
| Domain | DEXDc | 1.92e-04 | 109 | 143 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.02e-04 | 110 | 143 | 6 | IPR014001 | |
| Domain | Post-SET_dom | 2.29e-04 | 16 | 143 | 3 | IPR003616 | |
| Domain | PostSET | 2.29e-04 | 16 | 143 | 3 | SM00508 | |
| Domain | POST_SET | 2.29e-04 | 16 | 143 | 3 | PS50868 | |
| Domain | GLTP | 3.46e-04 | 4 | 143 | 2 | PF08718 | |
| Domain | Glycolipid_transfer_prot_dom | 3.46e-04 | 4 | 143 | 2 | IPR014830 | |
| Domain | TF_AF4/FMR2 | 3.46e-04 | 4 | 143 | 2 | IPR007797 | |
| Domain | AF-4 | 3.46e-04 | 4 | 143 | 2 | PF05110 | |
| Domain | Perilipin | 5.73e-04 | 5 | 143 | 2 | PF03036 | |
| Domain | Perilipin | 5.73e-04 | 5 | 143 | 2 | IPR004279 | |
| Domain | ANK | 7.11e-04 | 251 | 143 | 8 | SM00248 | |
| Domain | Ankyrin_rpt-contain_dom | 7.69e-04 | 254 | 143 | 8 | IPR020683 | |
| Domain | Ankyrin_rpt | 9.39e-04 | 262 | 143 | 8 | IPR002110 | |
| Domain | Znf_FYVE_PHD | 9.47e-04 | 147 | 143 | 6 | IPR011011 | |
| Domain | Helicase/UvrB_N | 1.58e-03 | 8 | 143 | 2 | IPR006935 | |
| Domain | ResIII | 1.58e-03 | 8 | 143 | 2 | PF04851 | |
| Domain | Ank | 1.89e-03 | 228 | 143 | 7 | PF00023 | |
| Domain | ZU5 | 2.02e-03 | 9 | 143 | 2 | SM00218 | |
| Domain | DEAD/DEAH_box_helicase_dom | 2.38e-03 | 73 | 143 | 4 | IPR011545 | |
| Domain | DEAD | 2.38e-03 | 73 | 143 | 4 | PF00270 | |
| Domain | ZU5 | 2.52e-03 | 10 | 143 | 2 | PS51145 | |
| Domain | - | 3.03e-03 | 248 | 143 | 7 | 1.25.40.20 | |
| Domain | ZF_CXXC | 3.06e-03 | 11 | 143 | 2 | PS51058 | |
| Domain | Znf_CXXC | 3.06e-03 | 11 | 143 | 2 | IPR002857 | |
| Domain | zf-CXXC | 3.06e-03 | 11 | 143 | 2 | PF02008 | |
| Domain | Znf_PHD-finger | 3.17e-03 | 79 | 143 | 4 | IPR019787 | |
| Domain | Znf_C2H2_matrin | 3.65e-03 | 12 | 143 | 2 | IPR000690 | |
| Domain | ZU5 | 3.65e-03 | 12 | 143 | 2 | PF00791 | |
| Domain | ZU5_dom | 3.65e-03 | 12 | 143 | 2 | IPR000906 | |
| Domain | SET | 3.79e-03 | 41 | 143 | 3 | PF00856 | |
| Domain | PHD | 4.86e-03 | 89 | 143 | 4 | SM00249 | |
| Domain | SET | 5.24e-03 | 46 | 143 | 3 | SM00317 | |
| Domain | Znf_PHD | 5.26e-03 | 91 | 143 | 4 | IPR001965 | |
| Domain | WW | 5.57e-03 | 47 | 143 | 3 | PF00397 | |
| Domain | - | 5.65e-03 | 148 | 143 | 5 | 2.60.40.150 | |
| Domain | WW | 5.91e-03 | 48 | 143 | 3 | SM00456 | |
| Domain | TPR-contain_dom | 5.98e-03 | 150 | 143 | 5 | IPR013026 | |
| Domain | ZF_PHD_2 | 6.12e-03 | 95 | 143 | 4 | PS50016 | |
| Domain | Ank_2 | 6.29e-03 | 215 | 143 | 6 | PF12796 | |
| Domain | ZF_PHD_1 | 6.35e-03 | 96 | 143 | 4 | PS01359 | |
| Domain | SET_dom | 6.62e-03 | 50 | 143 | 3 | IPR001214 | |
| Domain | SET | 6.62e-03 | 50 | 143 | 3 | PS50280 | |
| Domain | WW_DOMAIN_1 | 7.00e-03 | 51 | 143 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 7.00e-03 | 51 | 143 | 3 | PS50020 | |
| Domain | WW_dom | 7.39e-03 | 52 | 143 | 3 | IPR001202 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.30e-04 | 38 | 97 | 4 | MM17073 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.93e-04 | 42 | 97 | 4 | M48018 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.02e-04 | 175 | 97 | 7 | MM14941 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.39e-04 | 18 | 97 | 3 | MM1549 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DNA_END_RESECTION_AND_RPA_LOADING | 2.39e-04 | 18 | 97 | 3 | M47838 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 2.75e-04 | 46 | 97 | 4 | MM14933 | |
| Pubmed | MRPS31 VAPB UIMC1 RGPD2 MAP9 ANK2 RGPD8 NSD2 RGPD1 ANKS1B MYRIP ANKRD30B MAGI3 APOB ZFC3H1 ERBIN LUZP1 BPTF BRCA1 SBNO1 FAM186A CAPRIN2 KMT2A MACF1 BOD1L1 CEP295 CHD6 HADHA ATP1A4 GOLGB1 RGPD5 | 7.39e-14 | 1442 | 148 | 31 | 35575683 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | UIMC1 RAD18 MIS18BP1 NSD2 WRN MED1 WDR43 FSIP2 BPTF BRCA1 SBNO1 ZNF644 CFDP1 NFRKB KDM2B KMT2A BOD1L1 CHD6 SUZ12 LRIF1 AFF4 | 1.86e-13 | 608 | 148 | 21 | 36089195 |
| Pubmed | MRPS31 UIMC1 ZC3H14 ERCC3 KIF1A CDK12 NSD2 ESYT1 WRN ZFC3H1 MED1 RAB11FIP1 ANKHD1 ERBIN LUZP1 WDR43 C2CD2L BRCA1 NFRKB KDM2B KMT2A MACF1 CHD6 SUZ12 HCFC2 GOLGB1 AFF4 | 1.98e-10 | 1497 | 148 | 27 | 31527615 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VAPB UIMC1 ZC3H14 HIF1A RAD18 NSD2 ZC3H13 WRN FNBP4 ZFC3H1 MED1 SKIL WDR43 BPTF BRCA1 ZNF644 NFRKB ZNF638 KDM2B KMT2A CHD6 HADHA SUZ12 HCFC2 LRIF1 | 2.48e-10 | 1294 | 148 | 25 | 30804502 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | VAPB UIMC1 ZC3H14 SLK ANK2 CDK12 ESYT1 OAT MED1 ANKHD1 SYAP1 ERBIN WDR43 CFDP1 ZNF638 KMT2A MACF1 BOD1L1 SMCR8 GOLGB1 AFF4 | 5.45e-10 | 934 | 148 | 21 | 33916271 |
| Pubmed | MAP9 RAD18 AHI1 ANK3 WWP1 ZC3H13 APOB ANKHD1 ABLIM3 ERBIN TIA1 P2RX4 DDHD1 NFRKB ZNF638 MACF1 BOD1L1 CEP295 HERC1 TMEM181 GOLGB1 AFF4 | 1.36e-09 | 1084 | 148 | 22 | 11544199 | |
| Pubmed | ZC3H14 SLK ANK3 CDK12 FNBP4 MED1 ANKHD1 SYAP1 ERBIN LUZP1 BPTF NFRKB KDM2B KMT2A BOD1L1 RGPD5 | 1.93e-09 | 549 | 148 | 16 | 38280479 | |
| Pubmed | CNTN4 ANK2 ANK3 KIF1A ANKS1B MYRIP MAGI3 OAT DNAAF9 ZFC3H1 REV3L CMYA5 KDM6B SKIL ADARB1 SBNO1 NETO1 MACF1 SYT4 CHD6 ANKRD36 RAPGEF2 AFF4 | 5.95e-09 | 1285 | 148 | 23 | 35914814 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UIMC1 RAD18 CDK12 ZC3H13 FNBP4 MED1 ADARB1 SYAP1 ERBIN BPTF PRICKLE3 ZNF644 NFRKB ZNF638 KDM2B KMT2A SUZ12 PRG4 | 6.12e-09 | 774 | 148 | 18 | 15302935 |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.09e-08 | 7 | 148 | 4 | 15710750 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | UIMC1 ZC3H14 RAD18 CDK12 NSD2 ZC3H13 FNBP4 MED1 LUZP1 WDR43 BPTF BRCA1 ZNF644 NFRKB ZNF638 KMT2A BOD1L1 C2orf49 AFF4 | 2.69e-08 | 954 | 148 | 19 | 36373674 |
| Pubmed | UIMC1 RGPD2 ZC3H14 SLK RGPD8 RGPD1 ARFGEF1 ANKHD1 ERBIN RGPD5 | 3.20e-08 | 215 | 148 | 10 | 35973513 | |
| Pubmed | 8.89e-08 | 86 | 148 | 7 | 37253089 | ||
| Pubmed | UIMC1 SLK ERCC3 MIS18BP1 NSD2 MED1 ERBIN LUZP1 BRCA1 ZNF638 KMT2A CHD6 HADHA SUZ12 LRIF1 | 1.22e-07 | 645 | 148 | 15 | 25281560 | |
| Pubmed | CNTN4 RGPD2 SLK ANK2 RGPD8 ANK3 RGPD1 ANKS1B GABBR2 ABLIM3 ERBIN LUZP1 KCNB1 NETO1 MACF1 RAPGEF2 GOLGB1 AFF4 | 1.65e-07 | 963 | 148 | 18 | 28671696 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.18e-07 | 13 | 148 | 4 | 31427429 | |
| Pubmed | MRPS31 AFF2 ANK3 ESYT1 WRN ARFGEF1 MUC16 APOB ERBIN BRCA1 ZNF638 HCFC2 RAPGEF2 SMCR8 PLEKHA8 GOLGB1 | 2.34e-07 | 777 | 148 | 16 | 35844135 | |
| Pubmed | UIMC1 ANK3 CDK12 WWP1 FNBP4 L1TD1 SKIL ERBIN PPP1R26 CFDP1 MACF1 CHD6 HERC1 GOLGB1 | 2.63e-07 | 591 | 148 | 14 | 15231748 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.77e-07 | 271 | 148 | 10 | 32433965 | |
| Pubmed | RAD18 NSD2 WWP1 L1TD1 REV3L RAB11FIP1 ANKHD1 SKIL LUZP1 C2CD2L BPTF BRCA1 CAPRIN2 NFRKB MACF1 CEP295 SUZ12 RAPGEF2 AFF4 | 3.04e-07 | 1116 | 148 | 19 | 31753913 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HIF1A ANK3 KIF1A NSD2 WWP1 FNBP4 MYRIP MAGI3 SRCIN1 ADARB1 ERBIN CHRM3 BPTF NETO1 ZNF638 MACF1 BOD1L1 CHD6 RAPGEF2 TMEM181 GOLGB1 AFF4 | 3.68e-07 | 1489 | 148 | 22 | 28611215 |
| Pubmed | MRPS31 UIMC1 SLK RAD18 RGPD1 ANKHD1 ERBIN BPTF BRCA1 ZNF644 CFDP1 NFRKB ZNF638 KDM2B NCOA1 KMT2A CHD6 HADHA HCFC2 HERC1 LRIF1 | 7.61e-07 | 1429 | 148 | 21 | 35140242 | |
| Pubmed | 1.41e-06 | 251 | 148 | 9 | 31076518 | ||
| Pubmed | PLIN4 CNTN4 ATP8B4 MAGI3 ZFC3H1 USP37 ABLIM3 PPP1R26 VPS13D MACF1 FGD6 PDZRN4 | 1.47e-06 | 493 | 148 | 12 | 15368895 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | UIMC1 RAD18 MIS18BP1 SETD1B RGPD8 MYO9B C19orf47 LUZP1 ZNF644 KDM2B MACF1 LRIF1 GOLGB1 | 1.54e-06 | 588 | 148 | 13 | 38580884 |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | KIF1A SWT1 MUC16 APOB BPTF FAM186A PCNX1 CHD6 HERC1 C2orf49 GOLGB1 | 2.03e-06 | 420 | 148 | 11 | 28065597 |
| Pubmed | MIS18BP1 C19orf47 MUC19 WDR43 BRCA1 SBNO1 NFRKB KDM2B KMT2A LRIF1 | 2.10e-06 | 339 | 148 | 10 | 30415952 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 2.17e-06 | 22 | 148 | 4 | 26886794 | |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 2.61e-06 | 7 | 148 | 3 | 11353387 | |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 30944974 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 2.61e-06 | 7 | 148 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 2.61e-06 | 7 | 148 | 3 | 17372272 | |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 38657106 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 21205196 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 18949001 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 25187515 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 8603673 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 26632511 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 24403063 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 23818861 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 23536549 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 12191015 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 22821000 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 20682751 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MRPS31 VAPB DDX19A SLK ATP8B4 KIF1A NSD2 ESYT1 ARPC1A OAT APOB CMYA5 ANKHD1 SYAP1 WDR43 SBNO1 BOD1L1 HADHA SUZ12 TDRD6 | 2.87e-06 | 1425 | 148 | 20 | 30948266 |
| Pubmed | CDK12 NSD2 FNBP4 SRCIN1 KDM6B ANKHD1 WDR43 DDHD1 CAPRIN2 KDM2B PCNX1 CEP126 | 3.04e-06 | 529 | 148 | 12 | 14621295 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MRPS31 KRT26 LAMB4 KIF1A ZC3H13 MUC19 MAGI3 REV3L IGSF10 BOD1L1 CEP295 CHD6 HADHA PRG4 | 3.46e-06 | 736 | 148 | 14 | 29676528 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 3.55e-06 | 281 | 148 | 9 | 28706196 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.76e-06 | 283 | 148 | 9 | 30585729 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 4.16e-06 | 8 | 148 | 3 | 21670213 | |
| Pubmed | 4.16e-06 | 8 | 148 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 4.16e-06 | 8 | 148 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 4.16e-06 | 8 | 148 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 4.16e-06 | 8 | 148 | 3 | 28745977 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD2 DDX19A ERCC3 RGPD8 NSD2 C19orf47 RGPD1 BPTF ZNF638 SUZ12 | 4.57e-06 | 370 | 148 | 10 | 22922362 |
| Pubmed | 4.57e-06 | 57 | 148 | 5 | 18022353 | ||
| Pubmed | 5.32e-06 | 222 | 148 | 8 | 37071664 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | VAPB SLK ANK3 ESYT1 MAGI3 SRCIN1 ABLIM3 SYAP1 ERBIN LUZP1 MACF1 GOLGB1 | 5.93e-06 | 565 | 148 | 12 | 25468996 |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 6.23e-06 | 9 | 148 | 3 | 18394993 | |
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 28100513 | ||
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 17887960 | ||
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 11553612 | ||
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 10601307 | ||
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 9733766 | ||
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 28877029 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 7.11e-06 | 231 | 148 | 8 | 16452087 | |
| Pubmed | ZC3H14 AFF2 SWT1 CCDC90B CMYA5 ANKHD1 ERBIN IGSF10 NCOA1 CEP126 ATP1A4 FGD6 ALPK2 | 8.17e-06 | 686 | 148 | 13 | 29987050 | |
| Pubmed | 8.87e-06 | 10 | 148 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 8.87e-06 | 10 | 148 | 3 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 8.87e-06 | 10 | 148 | 3 | 8857542 | |
| Pubmed | 8.87e-06 | 10 | 148 | 3 | 21859863 | ||
| Pubmed | SLK SETD1B ERBIN C2CD2L ZNF644 MACF1 BOD1L1 CHD6 SUZ12 TMEM181 | 1.05e-05 | 407 | 148 | 10 | 12693553 | |
| Pubmed | VAPB ANK2 ANK3 ESYT1 ICE2 MAGI3 SYAP1 ERBIN MACF1 BOD1L1 HADHA SMCR8 GOLGB1 | 1.14e-05 | 708 | 148 | 13 | 39231216 | |
| Pubmed | VHL deletion impairs mammary alveologenesis but is not sufficient for mammary tumorigenesis. | 1.22e-05 | 11 | 148 | 3 | 20382704 | |
| Pubmed | 1.22e-05 | 11 | 148 | 3 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.22e-05 | 11 | 148 | 3 | 35771867 | |
| Pubmed | 1.22e-05 | 11 | 148 | 3 | 34110283 | ||
| Pubmed | 1.30e-05 | 251 | 148 | 8 | 27507650 | ||
| Pubmed | 1.60e-05 | 339 | 148 | 9 | 37232246 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.67e-05 | 341 | 148 | 9 | 32971831 | |
| Pubmed | Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3. | 1.80e-05 | 2 | 148 | 2 | 32151798 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 25538041 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23653235 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 32268270 | ||
| Pubmed | High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer. | 1.80e-05 | 2 | 148 | 2 | 18030615 | |
| Pubmed | Proteosomal degradation of NSD2 by BRCA1 promotes leukemia cell differentiation. | 1.80e-05 | 2 | 148 | 2 | 32826945 | |
| Pubmed | Epigenetic regulation of CD34 and HIF1A expression during the differentiation of human mast cells. | 1.80e-05 | 2 | 148 | 2 | 23529663 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21406551 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11355014 | ||
| Pubmed | WRN loss induces switching of telomerase-independent mechanisms of telomere elongation. | 1.80e-05 | 2 | 148 | 2 | 24709898 | |
| Pubmed | WRN functions in a RAD18-dependent damage avoidance pathway. | 1.80e-05 | 2 | 148 | 2 | 17541157 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 25164908 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18025805 | ||
| Pubmed | The Werner syndrome gene product (WRN): a repressor of hypoxia-inducible factor-1 activity. | 1.80e-05 | 2 | 148 | 2 | 22659133 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22539352 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27106595 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11781319 | ||
| Pubmed | Structural basis of diverse membrane target recognitions by ankyrins. | 1.80e-05 | 2 | 148 | 2 | 25383926 | |
| Interaction | NUP43 interactions | MIS18BP1 SETD1B RGPD8 CDK12 NSD2 ZC3H13 WRN MUC19 CCDC168 ZFC3H1 WDR43 FSIP2 BPTF BRCA1 NETO1 ZNF644 NFRKB KMT2A BOD1L1 CHD6 HCFC2 RAPGEF2 RGPD5 | 1.24e-10 | 625 | 145 | 23 | int:NUP43 |
| Interaction | CBX3 interactions | UIMC1 RAD18 MIS18BP1 CDK12 NSD2 ZC3H13 MED1 KDM6B USP37 SYAP1 WDR43 TGOLN2 BRCA1 SBNO1 ZNF644 CFDP1 NFRKB KDM2B KMT2A MACF1 SUZ12 LRIF1 | 1.39e-09 | 646 | 145 | 22 | int:CBX3 |
| Interaction | H3C3 interactions | UIMC1 RAD18 MIS18BP1 NSD2 MED1 WDR43 FSIP2 BPTF BRCA1 SBNO1 ZNF644 NFRKB KDM2B KMT2A BOD1L1 CHD6 SUZ12 LRIF1 AFF4 | 2.95e-09 | 495 | 145 | 19 | int:H3C3 |
| Interaction | TERF2IP interactions | UIMC1 ZC3H14 RAD18 CDK12 NSD2 MED1 BPTF BRCA1 SBNO1 ZNF644 CFDP1 NFRKB ZNF638 KDM2B KMT2A BOD1L1 SUZ12 LRIF1 AFF4 | 1.72e-08 | 552 | 145 | 19 | int:TERF2IP |
| Interaction | RGPD2 interactions | 1.28e-06 | 27 | 145 | 5 | int:RGPD2 | |
| Interaction | H3-3A interactions | UIMC1 RAD18 SETD1B NSD2 WRN MED1 KDM6B BPTF BRCA1 SBNO1 ZNF644 CFDP1 NFRKB KDM2B KMT2A BOD1L1 SUZ12 LRIF1 AFF4 | 1.86e-06 | 749 | 145 | 19 | int:H3-3A |
| Interaction | H2BC8 interactions | UIMC1 RAD18 MIS18BP1 NSD2 WDR43 BPTF BRCA1 SBNO1 ZNF644 CFDP1 NFRKB KDM2B KMT2A CHD6 SUZ12 LRIF1 | 4.14e-06 | 576 | 145 | 16 | int:H2BC8 |
| Interaction | NAA40 interactions | VAPB UIMC1 ZC3H14 SLK ANK2 CDK12 ESYT1 OAT MED1 ANKHD1 SYAP1 ERBIN WDR43 CFDP1 ZNF638 KMT2A MACF1 BOD1L1 SMCR8 GOLGB1 AFF4 | 7.02e-06 | 978 | 145 | 21 | int:NAA40 |
| Interaction | SMC5 interactions | UIMC1 ZC3H14 RAD18 CDK12 NSD2 ZC3H13 FNBP4 REV3L MED1 LUZP1 WDR43 BPTF BRCA1 ZNF644 NFRKB ZNF638 KMT2A BOD1L1 SUZ12 C2orf49 AFF4 | 9.85e-06 | 1000 | 145 | 21 | int:SMC5 |
| Interaction | RGPD4 interactions | 1.70e-05 | 22 | 145 | 4 | int:RGPD4 | |
| Interaction | DPY30 interactions | 1.73e-05 | 204 | 145 | 9 | int:DPY30 | |
| Interaction | AGAP2 interactions | 2.18e-05 | 210 | 145 | 9 | int:AGAP2 | |
| Interaction | PIN1 interactions | HIF1A CDK12 CCDC90B MED1 ADARB1 SYAP1 TGOLN2 SSC5D BRCA1 HADHA C2orf49 LRIF1 | 2.18e-05 | 383 | 145 | 12 | int:PIN1 |
| Interaction | RGPD1 interactions | 2.66e-05 | 49 | 145 | 5 | int:RGPD1 | |
| Interaction | CDK8 interactions | 3.37e-05 | 222 | 145 | 9 | int:CDK8 | |
| Interaction | NUP50 interactions | ZC3H14 RGPD8 CDK12 FNBP4 MED1 WDR43 SBNO1 CFDP1 KMT2A BOD1L1 SUZ12 | 3.73e-05 | 341 | 145 | 11 | int:NUP50 |
| Interaction | H2BC21 interactions | UIMC1 NSD2 FNBP4 KDM6B ADARB1 C2CD2L BPTF KIAA1549L BRCA1 ZNF644 CFDP1 ZNF638 KMT2A SUZ12 HCFC2 LRIF1 | 4.25e-05 | 696 | 145 | 16 | int:H2BC21 |
| Interaction | PLEKHA8P1 interactions | 5.14e-05 | 2 | 145 | 2 | int:PLEKHA8P1 | |
| Interaction | KCNA3 interactions | VAPB AFF2 ANK2 ANK3 ESYT1 ICE2 MAGI3 HELQ SYAP1 ERBIN LUZP1 CAPRIN2 KMT2A MACF1 BOD1L1 HADHA SMCR8 GOLGB1 | 5.54e-05 | 871 | 145 | 18 | int:KCNA3 |
| Interaction | SNRNP40 interactions | RAD18 MIS18BP1 CDK12 NSD2 ZC3H13 WRN ZFC3H1 USP37 WDR43 BRCA1 ZNF644 NFRKB KMT2A SUZ12 C2orf49 | 5.71e-05 | 637 | 145 | 15 | int:SNRNP40 |
| Interaction | YWHAG interactions | VAPB SLK CDK12 ESYT1 ZC3H13 C19orf47 MAGI3 RAB11FIP1 USP37 ERBIN LUZP1 TGOLN2 C2CD2L VPS13D PRICKLE3 ZNF638 KMT2A MACF1 BOD1L1 RAPGEF2 C2orf49 FGD6 | 8.50e-05 | 1248 | 145 | 22 | int:YWHAG |
| Interaction | H3C1 interactions | UIMC1 RAD18 SETD1B ANK2 ANK3 NSD2 ESYT1 KDM6B BPTF ZNF644 CFDP1 ZNF638 KDM2B KMT2A HADHA SUZ12 LRIF1 AFF4 | 8.53e-05 | 901 | 145 | 18 | int:H3C1 |
| Interaction | GTF3C4 interactions | 8.56e-05 | 195 | 145 | 8 | int:GTF3C4 | |
| Interaction | SMAD3 interactions | HIF1A ANK3 WWP1 APOB KDM6B SKIL ERBIN BPTF BRCA1 CFDP1 NCOA1 SUZ12 | 9.66e-05 | 447 | 145 | 12 | int:SMAD3 |
| Interaction | GPN3 interactions | 1.24e-04 | 107 | 145 | 6 | int:GPN3 | |
| Interaction | YWHAH interactions | VAPB ZC3H14 ESYT1 ZC3H13 C19orf47 MAGI3 MED1 RAB11FIP1 ERBIN LUZP1 VPS13D PRICKLE3 ZNF638 NCOA1 KMT2A MACF1 BOD1L1 HERC1 RAPGEF2 FGD6 | 1.25e-04 | 1102 | 145 | 20 | int:YWHAH |
| Interaction | CDH1 interactions | VAPB UIMC1 DDX19A SLK ANK3 ESYT1 MAGI3 SRCIN1 ABLIM3 SYAP1 ERBIN LUZP1 BRCA1 MACF1 HADHA GOLGB1 | 1.34e-04 | 768 | 145 | 16 | int:CDH1 |
| Interaction | H3C14 interactions | 1.38e-04 | 156 | 145 | 7 | int:H3C14 | |
| Interaction | ATRX interactions | 1.39e-04 | 267 | 145 | 9 | int:ATRX | |
| Interaction | YWHAQ interactions | VAPB SLK WWP1 ZC3H13 C19orf47 MED1 RAB11FIP1 ERBIN LUZP1 VPS13D BRCA1 ZNF638 NCOA1 KMT2A MACF1 HADHA RAPGEF2 C2orf49 FGD6 GOLGB1 | 1.52e-04 | 1118 | 145 | 20 | int:YWHAQ |
| Interaction | SPMAP2L interactions | 1.54e-04 | 3 | 145 | 2 | int:SPMAP2L | |
| Interaction | BAG2 interactions | HIF1A SLK RAD18 ESYT1 FNBP4 ZFC3H1 ANKHD1 SYAP1 ERBIN LUZP1 BPTF VPS13D NFRKB BOD1L1 | 1.63e-04 | 622 | 145 | 14 | int:BAG2 |
| Interaction | RAN interactions | RGPD2 RGPD8 RGPD1 ADARB1 IGSF10 TIA1 BRCA1 ZNF644 KMT2A SUZ12 CEP126 RGPD5 | 1.70e-04 | 475 | 145 | 12 | int:RAN |
| Interaction | HNF4A interactions | 1.73e-04 | 275 | 145 | 9 | int:HNF4A | |
| Interaction | RORA interactions | 1.74e-04 | 39 | 145 | 4 | int:RORA | |
| Interaction | NRCAM interactions | 2.12e-04 | 41 | 145 | 4 | int:NRCAM | |
| Interaction | ADARB1 interactions | RGPD2 ANK2 CDK12 NSD2 WRN RGPD1 MED1 ADARB1 BPTF ZNF638 HADHA ATP1A4 | 2.22e-04 | 489 | 145 | 12 | int:ADARB1 |
| Interaction | SETD1A interactions | 2.34e-04 | 170 | 145 | 7 | int:SETD1A | |
| Interaction | NPIPB6 interactions | 2.75e-04 | 18 | 145 | 3 | int:NPIPB6 | |
| Interaction | C2CD4B interactions | 2.79e-04 | 44 | 145 | 4 | int:C2CD4B | |
| Interaction | BUB3 interactions | 2.82e-04 | 232 | 145 | 8 | int:BUB3 | |
| Interaction | PLEC interactions | SLK ANK3 CDK12 NSD2 ADARB1 LUZP1 BRCA1 CCDC68 MACF1 SUZ12 RAPGEF2 | 2.87e-04 | 430 | 145 | 11 | int:PLEC |
| GeneFamily | Ankyrin repeat domain containing | ANK2 ANK3 ANKS1B ANKRD30B ANKRD36C ANKHD1 ANKRD36B ANKRD36 ANKFN1 | 8.51e-06 | 242 | 101 | 9 | 403 |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.84e-04 | 4 | 101 | 2 | 1145 | |
| GeneFamily | Perilipins | 3.06e-04 | 5 | 101 | 2 | 678 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 4.57e-04 | 6 | 101 | 2 | 1328 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.93e-04 | 34 | 101 | 3 | 487 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.08e-03 | 9 | 101 | 2 | 1280 | |
| GeneFamily | PHD finger proteins | 1.62e-03 | 90 | 101 | 4 | 88 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.64e-03 | 11 | 101 | 2 | 1315 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.64e-03 | 11 | 101 | 2 | 1168 | |
| GeneFamily | Zinc fingers CXXC-type | 1.97e-03 | 12 | 101 | 2 | 136 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.95e-03 | 115 | 101 | 4 | 769 | |
| GeneFamily | CD molecules|Mucins | 6.05e-03 | 21 | 101 | 2 | 648 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CNTN4 AFF2 ANK2 ANK3 KIF1A ANKS1B MUC19 ARFGEF1 MAGI3 SRCIN1 REV3L GABBR2 ABLIM3 NCR3LG1 ANKRD36B FSIP2 ZNF385D KIAA1549L NETO1 CAPRIN2 KDM2B SYT4 BOD1L1 ANKRD36 CEP126 HCFC2 HERC1 PDZRN4 | 1.89e-11 | 1106 | 147 | 28 | M39071 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MRPS31 SLK RAD18 AHI1 MIS18BP1 ICE2 WWP1 WRN L1TD1 ARFGEF1 REV3L ANKHD1 BPTF CSGALNACT2 BRCA1 ZNF644 CAPRIN2 ZNF638 SUZ12 GOLGB1 | 8.47e-10 | 656 | 147 | 20 | M18979 |
| Coexpression | GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN | HIF1A ICE2 DNAAF9 REV3L ZFP69 SBNO1 CAPRIN2 KDM2B KMT2A CHD6 AFF4 | 1.76e-08 | 199 | 147 | 11 | M6030 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | SLK AHI1 PSG4 PSG7 WRN FNBP4 RAB11FIP1 KDM6B SKIL PLIN2 CSGALNACT2 SBNO1 CCDC68 NCOA1 PCNX1 FGD6 LRIF1 GOLGB1 AFF4 RGPD5 | 3.75e-08 | 822 | 147 | 20 | M6782 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZC3H14 HIF1A SLK MYO9B WWP1 WRN ARFGEF1 REV3L MED1 ABLIM3 ADARB1 WDR43 BPTF TIA1 BRCA1 ZNF638 NCOA1 MACF1 SUZ12 RAPGEF2 | 7.25e-08 | 856 | 147 | 20 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 8.49e-07 | 180 | 147 | 9 | M8239 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD2 RGPD8 ANK3 RGPD1 FNBP4 MED1 HELQ LUZP1 P2RX4 C2orf49 SMCR8 AFF4 RGPD5 | 2.90e-06 | 474 | 147 | 13 | M40991 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SLK MIS18BP1 MYO9B ESYT1 FNBP4 ZFC3H1 REV3L MED1 ADARB1 ERBIN LUZP1 TGOLN2 BPTF CSGALNACT2 SBNO1 ZNF644 ZNF638 NCOA1 KMT2A MACF1 PCNX1 BOD1L1 SUZ12 HERC1 | 2.95e-06 | 1492 | 147 | 24 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SLK WRN ARFGEF1 REV3L ADARB1 WDR43 BPTF BRCA1 ZNF638 NCOA1 SUZ12 RAPGEF2 | 1.33e-05 | 466 | 147 | 12 | M13522 |
| Coexpression | ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1 | 1.72e-05 | 96 | 147 | 6 | M39216 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 1.80e-05 | 200 | 147 | 8 | M9889 | |
| Coexpression | GSE557_CIITA_KO_VS_I_AB_KO_DC_DN | 1.80e-05 | 200 | 147 | 8 | M6014 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | ANK2 ANK3 MUC19 MYRIP MUC16 SRCIN1 GABBR2 ANKRD36B ZNF385D SYT4 CEP126 PDZRN4 | 2.99e-05 | 506 | 147 | 12 | M39067 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | RGPD2 MAP9 AHI1 ANK2 RGPD8 KIF1A PSG4 MAGI3 ANKRD36C CHRM3 LUZP1 ANKRD36B ADGB TDRD6 RAPGEF2 PDZRN4 | 3.33e-05 | 873 | 147 | 16 | M16009 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | ANK2 ANK3 MYRIP SRCIN1 REV3L GABBR2 ABLIM3 ANKRD36B ZNF385D KIAA1549L SYT4 PDZRN4 | 1.17e-04 | 584 | 147 | 12 | M39068 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | RGPD8 CDK12 FNBP4 ZFC3H1 KDM6B SYAP1 ZNF644 NFRKB NCOA1 BOD1L1 RAPGEF2 AFF4 RGPD5 | 1.24e-04 | 680 | 147 | 13 | M41089 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | CNTN4 ZC3H13 ANKS1B MYRIP ZFC3H1 GABBR2 CHRM3 CFDP1 CHD6 GOLGB1 | 1.28e-04 | 417 | 147 | 10 | M39224 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP | RAB11FIP1 KDM6B USP37 SKIL PLIN2 CSGALNACT2 P2RX4 NCOA1 PCNX1 CHD6 RAPGEF2 SMCR8 PLEKHA8 GOLGB1 | 1.28e-04 | 778 | 147 | 14 | M17915 |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP | 1.40e-04 | 200 | 147 | 7 | M7594 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 1.40e-04 | 200 | 147 | 7 | M9321 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | RAD18 ANK3 NSD2 WWP1 WRN SRCIN1 DNAAF9 ANKHD1 SKIL ERBIN SSC5D BRCA1 DDHD1 SYT4 PCNX1 CEP295 PDZRN4 | 1.55e-04 | 1102 | 147 | 17 | M2369 |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.60e-04 | 143 | 147 | 6 | M9149 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | RAD18 AHI1 MIS18BP1 ANK2 KIF1A SWT1 NSD2 ICE2 ZC3H13 REV3L ZFP69 LUZP1 BPTF KIAA1549L BRCA1 SBNO1 ZNF644 MACF1 BOD1L1 CEP295 SUZ12 CEP126 RAPGEF2 ANKFN1 LRIF1 PLEKHA8 | 4.21e-07 | 1257 | 146 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | RAD18 AHI1 MIS18BP1 AFF2 ANK2 KIF1A SWT1 NSD2 ICE2 ZC3H13 ANKS1B REV3L ZFP69 LUZP1 BPTF KIAA1549L BRCA1 SBNO1 ZNF644 MACF1 BOD1L1 CEP295 SUZ12 CEP126 RAPGEF2 ANKFN1 LRIF1 PLEKHA8 | 6.39e-07 | 1459 | 146 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | MIS18BP1 REV3L ZFP69 LUZP1 ZNF644 MOV10L1 ZNF638 MACF1 CEP126 FGD6 GOLGB1 | 7.07e-06 | 298 | 146 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | SLK MIS18BP1 AFF2 ICE2 ARFGEF1 REV3L ZFP69 LUZP1 MACF1 BOD1L1 CEP295 FGD6 GOLGB1 | 9.36e-06 | 432 | 146 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | AHI1 MIS18BP1 ANK2 KIF1A SWT1 NSD2 ICE2 ZC3H13 MYRIP ZFP69 KIAA1549L BRCA1 ZNF644 CAPRIN2 MACF1 BOD1L1 CEP295 CEP126 HERC1 LRIF1 PLEKHA8 | 1.21e-05 | 1060 | 146 | 21 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | UIMC1 MIS18BP1 KIF1A DNAAF9 REV3L ZFP69 LUZP1 KIAA1549L PRICKLE3 ZNF644 MOV10L1 CCDC68 ZNF638 NCOA1 MACF1 CEP126 FGD6 LRIF1 PLEKHA8 GOLGB1 | 1.28e-05 | 979 | 146 | 20 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | CNTN4 HIF1A RAD18 ATP8B4 MIS18BP1 CDK12 ICE2 ZC3H13 KDM6B ANKHD1 ADARB1 TIA1 BRCA1 SBNO1 MOV10L1 CEP295 HERC1 | 2.52e-05 | 776 | 146 | 17 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | AHI1 MIS18BP1 AFF2 ANK2 KIF1A SWT1 NSD2 ICE2 ZC3H13 ANKS1B MYRIP ZFP69 KIAA1549L BRCA1 ZNF644 CAPRIN2 MACF1 BOD1L1 CEP295 CEP126 HERC1 ANKFN1 LRIF1 PLEKHA8 | 3.48e-05 | 1414 | 146 | 24 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | AHI1 ERCC3 MIS18BP1 AFF2 ANK3 SWT1 ICE2 ZFP69 ERBIN LUZP1 IGSF10 KIAA1549L BRCA1 SBNO1 ZNF644 MACF1 BOD1L1 CEP295 SUZ12 CEP126 LRIF1 PLEKHA8 | 4.04e-05 | 1241 | 146 | 22 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.49e-05 | 186 | 146 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | RAD18 MIS18BP1 SWT1 CDK12 ICE2 L1TD1 MAGI3 USP37 ADARB1 BRCA1 DDHD1 MOV10L1 CAPRIN2 HFM1 CEP295 HERC1 FGD6 | 5.02e-05 | 820 | 146 | 17 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | RAD18 MIS18BP1 SWT1 CDK12 NSD2 MUC19 L1TD1 RAB11FIP1 USP37 WDR43 BRCA1 DDHD1 MOV10L1 CAPRIN2 HFM1 SUZ12 FGD6 | 5.17e-05 | 822 | 146 | 17 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | DDX19A RAD18 MIS18BP1 SWT1 ICE2 REV3L ANKHD1 HELQ ERBIN LUZP1 BRCA1 ZNF644 MOV10L1 MACF1 C2orf49 AFF4 | 9.58e-05 | 780 | 146 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.13e-04 | 110 | 146 | 6 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | VAPB HIF1A RAD18 MIS18BP1 ZC3H13 FNBP4 L1TD1 KDM6B ANKHD1 TIA1 BRCA1 SBNO1 MOV10L1 ZNF638 CEP295 HERC1 | 1.40e-04 | 806 | 146 | 16 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.45e-04 | 115 | 146 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | RAD18 AHI1 MIS18BP1 AFF2 ANK2 KIF1A NSD2 ZC3H13 MYRIP ZFC3H1 REV3L USP37 BPTF KIAA1549L BRCA1 CAPRIN2 KDM2B BOD1L1 CEP295 CEP126 ANKFN1 PLEKHA8 | 1.71e-04 | 1370 | 146 | 22 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.89e-04 | 291 | 146 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 2.02e-04 | 78 | 146 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.09e-04 | 311 | 146 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | AHI1 ERCC3 MIS18BP1 AFF2 ANK3 SWT1 ICE2 ZFP69 ERBIN LUZP1 IGSF10 KIAA1549L BRCA1 SBNO1 ZNF644 MACF1 BOD1L1 CEP295 SUZ12 CEP126 LRIF1 PLEKHA8 | 4.45e-04 | 1468 | 146 | 22 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | SLK MIS18BP1 AFF2 ICE2 ARFGEF1 REV3L ZFP69 LUZP1 SSC5D CCDC68 MACF1 BOD1L1 CEP295 FGD6 TMEM181 LRIF1 GOLGB1 | 4.64e-04 | 989 | 146 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CNTN4 AHI1 ANK3 ANKS1B MYRIP GABBR2 CHRM3 ANKRD36B KIAA1549L NETO1 ANKRD36 HERC1 | 3.26e-12 | 198 | 148 | 12 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ANK3 ARFGEF1 ZFC3H1 ANKRD36C BPTF ZNF644 DDHD1 MACF1 ANKRD36 HERC1 GOLGB1 RGPD5 | 3.46e-12 | 199 | 148 | 12 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | MAP9 MIS18BP1 ZC3H13 ANKRD36B BPTF VPS13D SBNO1 ZNF644 BOD1L1 ANKRD36 CEP126 GOLGB1 | 3.46e-12 | 199 | 148 | 12 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | CNTN4 AHI1 ANK3 ANKS1B MYRIP GABBR2 CHRM3 ANKRD36B KIAA1549L KCNB1 ANKRD36 HERC1 | 3.67e-12 | 200 | 148 | 12 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SLK ANK3 NSD2 MUC16 ANKRD36C CMYA5 RAB11FIP1 ANKRD36B MACF1 GOLGB1 AFF4 | 2.31e-11 | 179 | 148 | 11 | 6e965e424eebef50f0202cff75f458be395cfca1 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | CDK12 WWP1 ZC3H13 MED1 USP37 ERBIN LUZP1 VPS13D ZNF644 BOD1L1 CEP295 | 3.50e-11 | 186 | 148 | 11 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | ARFGEF1 ANKRD36C ZNF644 DDHD1 KMT2A MACF1 PCNX1 ANKRD36 HERC1 RAPGEF2 GOLGB1 | 3.93e-11 | 188 | 148 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIF1A ARFGEF1 REV3L KCNB1 NCOA1 KMT2A MACF1 BOD1L1 HERC1 GOLGB1 AFF4 | 5.82e-11 | 195 | 148 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | AHI1 ZC3H13 ZFC3H1 ANKRD36C CFDP1 CAPRIN2 ZNF638 BOD1L1 CEP295 ANKRD36 GOLGB1 | 6.49e-11 | 197 | 148 | 11 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | WWP1 ZC3H13 ARFGEF1 REV3L BPTF SBNO1 ZNF644 CCDC68 BOD1L1 ANKRD36 GOLGB1 | 7.23e-11 | 199 | 148 | 11 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIF1A ARFGEF1 REV3L KCNB1 NCOA1 KMT2A MACF1 BOD1L1 HERC1 GOLGB1 | 1.13e-09 | 195 | 148 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CNTN4 AHI1 ANKS1B MYRIP GABBR2 CHRM3 ANKRD36B KIAA1549L KCNB1 ANKRD36 | 1.18e-09 | 196 | 148 | 10 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-08 | 191 | 148 | 9 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | ANK3 ARFGEF1 ANKRD36C ANKRD36B KMT2A MACF1 PCNX1 ANKRD36 HERC1 | 1.71e-08 | 192 | 148 | 9 | 47646d7e4990be85072987f92bf18d52f8da752e |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.79e-08 | 193 | 148 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.23e-08 | 198 | 148 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.11e-07 | 171 | 148 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.44e-07 | 177 | 148 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.69e-07 | 192 | 148 | 8 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.02e-07 | 195 | 148 | 8 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 3.14e-07 | 196 | 148 | 8 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-07 | 198 | 148 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-07 | 198 | 148 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 3.53e-07 | 199 | 148 | 8 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 3.53e-07 | 199 | 148 | 8 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.53e-07 | 199 | 148 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.53e-07 | 199 | 148 | 8 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.67e-07 | 200 | 148 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-07 | 200 | 148 | 8 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.67e-07 | 200 | 148 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 4.08e-07 | 138 | 148 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.20e-06 | 162 | 148 | 7 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-06 | 167 | 148 | 7 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | COVID-19_Mild-Neu_2|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.79e-06 | 172 | 148 | 7 | f5fd08b42c002d4693646b27e7b708eceb49524f | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-06 | 176 | 148 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 2.43e-06 | 180 | 148 | 7 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.52e-06 | 181 | 148 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-06 | 184 | 148 | 7 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 3.07e-06 | 120 | 148 | 6 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.35e-06 | 189 | 148 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-06 | 191 | 148 | 7 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-06 | 191 | 148 | 7 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.72e-06 | 192 | 148 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 192 | 148 | 7 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.85e-06 | 193 | 148 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.98e-06 | 194 | 148 | 7 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.98e-06 | 194 | 148 | 7 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.40e-06 | 197 | 148 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.55e-06 | 198 | 148 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 4.55e-06 | 198 | 148 | 7 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 4.70e-06 | 199 | 148 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 6.06e-06 | 135 | 148 | 6 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.06e-06 | 135 | 148 | 6 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.88e-06 | 147 | 148 | 6 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.15e-05 | 151 | 148 | 6 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-05 | 155 | 148 | 6 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.39e-05 | 156 | 148 | 6 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.39e-05 | 156 | 148 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.39e-05 | 156 | 148 | 6 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-05 | 156 | 148 | 6 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 160 | 148 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 160 | 148 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-05 | 162 | 148 | 6 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-05 | 165 | 148 | 6 | 1d0f60bf47a40ac916f0fcb5532a968742a0edbb | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.11e-05 | 168 | 148 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.25e-05 | 170 | 148 | 6 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.33e-05 | 171 | 148 | 6 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.65e-05 | 175 | 148 | 6 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.41e-05 | 183 | 148 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-05 | 185 | 148 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.96e-05 | 188 | 148 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 188 | 148 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 4.08e-05 | 189 | 148 | 6 | 8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 4.08e-05 | 189 | 148 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|COVID-19_Convalescent / Disease condition and Cell class | 4.08e-05 | 189 | 148 | 6 | 732e8dcffcb634ca2968f9170c9c4b31dd5d4206 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.20e-05 | 190 | 148 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-05 | 190 | 148 | 6 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-05 | 190 | 148 | 6 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.20e-05 | 190 | 148 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-05 | 190 | 148 | 6 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-05 | 190 | 148 | 6 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.20e-05 | 190 | 148 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 193 | 148 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 193 | 148 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 193 | 148 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.72e-05 | 194 | 148 | 6 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.85e-05 | 195 | 148 | 6 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.85e-05 | 195 | 148 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.14e-05 | 197 | 148 | 6 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.14e-05 | 197 | 148 | 6 | 4a6eff66a17c5e89bda61d887b736f5c62b93bd7 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.28e-05 | 198 | 148 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.28e-05 | 198 | 148 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 199 | 148 | 6 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 199 | 148 | 6 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 5.43e-05 | 199 | 148 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.43e-05 | 199 | 148 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 199 | 148 | 6 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-05 | 199 | 148 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 5.43e-05 | 199 | 148 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.43e-05 | 199 | 148 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.99e-06 | 50 | 82 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.70e-05 | 50 | 82 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Disease | lung adenocarcinoma | 1.96e-04 | 174 | 141 | 6 | EFO_0000571 | |
| Disease | response to tenofovir, creatinine clearance measurement | 2.07e-04 | 112 | 141 | 5 | EFO_0007934, EFO_0009279 | |
| Disease | Weaver syndrome | 2.25e-04 | 5 | 141 | 2 | C0265210 | |
| Disease | response to silica exposure, pneumoconiosis | 2.25e-04 | 5 | 141 | 2 | EFO_0005853, MONDO_0015926 | |
| Disease | chemotherapy-induced cytotoxicity measurement | 3.36e-04 | 6 | 141 | 2 | EFO_0010978 | |
| Disease | glucagon measurement, glucose tolerance test | 3.36e-04 | 6 | 141 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | cerebrospinal fluid clusterin measurement | 6.25e-04 | 35 | 141 | 3 | EFO_0007657 | |
| Disease | age at menopause | 6.45e-04 | 302 | 141 | 7 | EFO_0004704 | |
| Disease | white matter hyperintensity measurement | 6.45e-04 | 302 | 141 | 7 | EFO_0005665 | |
| Disease | Malignant neoplasm of breast | HIF1A ERCC3 ANK2 NSD2 HELQ BRCA1 SBNO1 PRICKLE3 ZNF644 NCOA1 MACF1 BOD1L1 PLEKHA8 GOLGB1 | 6.53e-04 | 1074 | 141 | 14 | C0006142 |
| Disease | age of onset of depressive disorder, wellbeing measurement | 9.95e-04 | 10 | 141 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | 1.21e-03 | 11 | 141 | 2 | EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175 | |
| Disease | dimethylglycine measurement | 1.39e-03 | 46 | 141 | 3 | EFO_0010476 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 1.42e-03 | 101 | 141 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Intellectual Disability | 1.43e-03 | 447 | 141 | 8 | C3714756 | |
| Disease | nervous system disease (implicated_via_orthology) | 1.45e-03 | 12 | 141 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | alcohol and nicotine codependence | 1.71e-03 | 13 | 141 | 2 | EFO_0004776 | |
| Disease | skin melanoma (is_marker_for) | 1.71e-03 | 13 | 141 | 2 | DOID:8923 (is_marker_for) | |
| Disease | monoclonal gammopathy | 2.10e-03 | 53 | 141 | 3 | EFO_0000203 | |
| Disease | R-6-hydroxywarfarin measurement | 2.22e-03 | 114 | 141 | 4 | EFO_0803327 | |
| Disease | waist-hip ratio | PLIN4 ANK3 MYO9B ARFGEF1 ABLIM3 ZNF385D BPTF SSC5D CD34 CAPRIN2 SYT4 PCNX1 SLC14A2 PDZRN4 | 2.27e-03 | 1226 | 141 | 14 | EFO_0004343 |
| Disease | cognitive decline measurement | 2.40e-03 | 486 | 141 | 8 | EFO_0007710 | |
| Disease | ovarian cancer (is_implicated_in) | 2.46e-03 | 56 | 141 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | cD177 antigen measurement | 3.30e-03 | 18 | 141 | 2 | EFO_0021866 | |
| Disease | Schizophrenia | AHI1 ANK3 MYO9B CMYA5 ADARB1 BRCA1 KCNB1 SBNO1 CCDC68 KDM2B KMT2A | 3.51e-03 | 883 | 141 | 11 | C0036341 |
| Disease | cerebral infarction (is_marker_for) | 3.68e-03 | 19 | 141 | 2 | DOID:3526 (is_marker_for) | |
| Disease | breast carcinoma (is_marker_for) | 3.92e-03 | 66 | 141 | 3 | DOID:3459 (is_marker_for) | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.45e-03 | 69 | 141 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.52e-03 | 139 | 141 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Neoplastic Cell Transformation | 4.52e-03 | 139 | 141 | 4 | C0007621 | |
| Disease | forced expiratory volume | ATP8B4 CDK12 MED1 ABLIM3 CHRM3 SSC5D CFDP1 ANKFN1 FGD6 SLC14A2 | 4.73e-03 | 789 | 141 | 10 | EFO_0004314 |
| Disease | bipolar I disorder | 4.76e-03 | 141 | 141 | 4 | EFO_0009963 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTAKDSAKTTFTSIT | 121 | Q9H6B1 | |
| SVELTSKSGVQVEKT | 361 | Q68DN1 | |
| GSSTSTSIKVKKTEN | 106 | Q9BVC5 | |
| VKSLKSKSETEQETT | 286 | Q5W0A0 | |
| DINKDVGVKTSESTT | 526 | Q96RT1 | |
| VGVKTSESTTTVKSK | 531 | Q96RT1 | |
| SESTTTVKSKVDERE | 536 | Q96RT1 | |
| TVGDSSHKTKTISQT | 826 | Q9BSJ8 | |
| ATKSKTSEDISQTSK | 456 | O94929 | |
| SRKETTSGTSTEPVK | 1066 | Q9NYV4 | |
| KSTSDSEIISVSDTQ | 871 | Q9BXX2 | |
| QDSQVTSTKSKSSAE | 366 | Q8N9M1 | |
| TSTKSKSSAEVKVTI | 371 | Q8N9M1 | |
| GEQKKESSVRSVSSD | 261 | Q8N157 | |
| TISEGQKSSVTSKTT | 1306 | Q8N7X0 | |
| EAKTLQTSTDSVSKE | 611 | Q86TB3 | |
| SASAVNEEVSKIKST | 1591 | Q9Y6D6 | |
| TTSETVSQRTIGKKQ | 616 | P51816 | |
| DTAKTSDVNSSVGKS | 436 | P20309 | |
| SSTSVIETNKTSVEL | 946 | Q8IWV2 | |
| ATSVKKDSVSNIATE | 1201 | A6QL64 | |
| TSVKKDSVSNIATEI | 606 | Q8N2N9 | |
| KTTDTVSSFSQDKTV | 1176 | Q8TF62 | |
| SKAVSTSELKTEGVS | 311 | Q9H2F9 | |
| KEQSKTVVTTTVTDS | 1776 | Q12830 | |
| TTTEFTKKDTQTKSI | 191 | Q9GZT6 | |
| TKKDTQTKSIISETS | 196 | Q9GZT6 | |
| SSQKSREIIETDTSS | 636 | Q9UHB7 | |
| ADASKSVQVSTLKTE | 231 | Q92747 | |
| SSKESTSTKAKTTEQ | 786 | Q6ZMN7 | |
| GTEKQTTSETQKSVQ | 26 | Q8TDF5 | |
| ETDSVVSSVTTKVKG | 56 | Q99571 | |
| TVTITKEDESTEKLS | 371 | Q9NS91 | |
| ASEVEVSSTSETTTK | 1516 | Q99666 | |
| ASEVEVSSTSETTTK | 1516 | O14715 | |
| SVEEKSSKISNITVE | 446 | Q7Z3Y9 | |
| SVSATEKKNTIDVLS | 1016 | Q9UPP5 | |
| TTTTTTITEKHKLNV | 821 | Q01484 | |
| EQTGETKESTKTETT | 2256 | Q01484 | |
| TKESTKTETTTEIRS | 2261 | Q01484 | |
| SATSSIQKTEVTKTD | 2866 | Q01484 | |
| ATSVKKDSVSNIATE | 1031 | Q5JPF3 | |
| SQKTKSETVTGELSK | 316 | Q7Z6G8 | |
| TETSTVSLDNETTVK | 2336 | Q8WXI7 | |
| VKDETSLTTFSTKSE | 541 | Q9Y5Z7 | |
| KSSQALTSAKTTVVV | 466 | Q9BXT6 | |
| SERTTEGTSQQKVKE | 306 | Q6P0N0 | |
| KKVTTGETSSSNDKI | 1386 | Q5TCQ9 | |
| TTAVEKSKESQVTAD | 296 | Q49MG5 | |
| ISTSATASSKKTIED | 341 | Q49MG5 | |
| SIEKISSSVDATTVT | 506 | Q5T3J3 | |
| VSVADQKGKSTVASS | 1066 | Q6P4R8 | |
| TTTATTDELKTVTKD | 616 | Q16665 | |
| TVTSGKSIDDNSTKS | 391 | Q68D85 | |
| SSKQDIRGTKTEQST | 1681 | Q2LD37 | |
| SDDVKSQSTTSSKSE | 2446 | Q15751 | |
| TTTTTTTATQEEEKK | 756 | O15054 | |
| VSKVTSTTTVKSKDT | 5536 | Q5CZC0 | |
| ISRDSAQSVTTKKVS | 5721 | Q5CZC0 | |
| TAATIKGDTDTAKTS | 166 | Q96RV3 | |
| GKTGTTKTSVEESRT | 6096 | Q7Z5P9 | |
| ETQTEVSVSSKKSER | 646 | O96028 | |
| QDGSTIKTAKSTETR | 1271 | Q6ZVL6 | |
| VDKTKEVTTTGVSNS | 131 | Q96JA3 | |
| TDVKDAKVISVSTGT | 361 | P78563 | |
| QGKATSSETKESTDI | 1446 | Q9UPN3 | |
| TTDKQSSKENTRTVE | 36 | Q49AM1 | |
| GVAQKSEIKESTISS | 1161 | A2PYH4 | |
| VTSFSTDTEKTKISG | 1281 | A2PYH4 | |
| VKGASETTTKGTSTE | 401 | O43900 | |
| EQSTSEKAVLTSQKS | 1446 | P38398 | |
| TKTQTSDSSEGKTKS | 451 | Q8NFC6 | |
| TVKTRKGNVATEIST | 191 | P04114 | |
| SKVKSILESVTSESN | 316 | Q8N6G5 | |
| TQVKKGEETEETSSS | 131 | Q9UEE9 | |
| IISKDSSTKSIISTQ | 1301 | Q6WRI0 | |
| TELETFGVTTTKVSK | 401 | Q659A1 | |
| SETSSSKSFETKEQG | 496 | Q14721 | |
| RTLSNESEESVKSTT | 471 | Q8NHM5 | |
| KVEVTEKTTTVLSES | 471 | O14523 | |
| STTKSGTAVTEKTAE | 2556 | Q8TD26 | |
| TKKSREDSISENVTT | 686 | Q9P2H0 | |
| SVEQVKSETISSSVK | 2056 | Q8N3K9 | |
| VKEKDGTVTTETSSV | 486 | Q5TEA3 | |
| QTEDSKSTVEAKGSI | 2681 | Q12955 | |
| QVSQSEKTKALTTSS | 3891 | Q12955 | |
| KEVSEASKESSVNST | 286 | Q494V2 | |
| KTQLSKTESVKESES | 341 | Q6IMN6 | |
| KGKVEKTTRTFSDTT | 501 | Q86V48 | |
| IITTEKTSKDTSASA | 511 | P40939 | |
| QKKEDSKTSTSVTSV | 766 | O75899 | |
| TSVTLGDTTAVKTKI | 946 | Q03164 | |
| GEKRVTITEKSVASS | 2956 | Q03164 | |
| AEKKINETSSTINTS | 1321 | A4D0S4 | |
| SDATTSKIARTVTQK | 361 | Q8NEL9 | |
| TETFTSKSAISKTAE | 211 | P19447 | |
| ETIDGVISSNVKSTK | 3641 | Q8NDH2 | |
| HISSGTITSKEEKTE | 611 | A6NE01 | |
| SEEINVAKKTVESSS | 296 | Q8TDG4 | |
| TSQSTSVSTKKEDET | 426 | Q8N8Z6 | |
| KADTNGIIKTSTTAE | 31 | Q9NUU7 | |
| STTSKEEETNIISSI | 1996 | Q9C0D2 | |
| TGKESSKSITVKVSD | 401 | Q00888 | |
| TAATDVSNGTVKKES | 181 | A3KN83 | |
| EATTNITETTVKFTS | 81 | P28906 | |
| SVDSSKKTSESKNVG | 1371 | Q15648 | |
| DAETNITTEKVSKIS | 231 | Q12756 | |
| ASEVEVSSTSETTTK | 1501 | P0DJD0 | |
| TSKAVLTGTKDTVST | 146 | Q96Q06 | |
| VDTSKTVLTGTKDTV | 276 | Q96Q06 | |
| TTKSVLTGTKDAVST | 476 | Q96Q06 | |
| VAKGTVQTSVDTTKT | 696 | Q96Q06 | |
| DTTKSVLTGTKDAVS | 871 | Q96Q06 | |
| DKQSVRTEETSKETS | 71 | Q92665 | |
| DKTKEVTTTGVSNSE | 16 | O95397 | |
| SSTSLTSEEKQEKLG | 141 | Q9H2B2 | |
| TSTAESQKKATAEGS | 1121 | Q6WKZ4 | |
| SVTTSKIVTDSDSKT | 806 | Q9H2G2 | |
| ELSTQVIKSASSKSV | 1486 | O60522 | |
| TSAVSQSKELTKTEA | 416 | P12757 | |
| QAIKIETTSSKVESS | 226 | Q969N4 | |
| KETSTTVEEATTIVK | 356 | Q8N3X1 | |
| EVEVSSTSETTTKAV | 1511 | P0DJD1 | |
| SSTSTGESSKEAQKV | 641 | Q5VVP1 | |
| KSDISSSSQGVIEKE | 96 | Q15788 | |
| KKDSASTSVSVTGQV | 711 | Q15788 | |
| ETVSIVTSKAEATSS | 1141 | Q9UPS6 | |
| RSKVTTTQENEGSTK | 306 | Q5T8A7 | |
| KRSKEEVGINTETSS | 1386 | Q14191 | |
| SAATKKITESVAETA | 66 | Q96A49 | |
| VRNSATGKESSKSVT | 396 | Q13046 | |
| TGKESSKSVTVRVSD | 401 | Q13046 | |
| ASVTASVLEKTTTKA | 606 | A1L4H1 | |
| SSENTVTKKQEGTSL | 716 | Q5T5J6 | |
| SVASATSVATKKTVQ | 21 | P04181 | |
| SKETSLTVNKETTVE | 271 | Q92954 | |
| LTVNKETTVETKETT | 276 | Q92954 | |
| ETTVETKETTTTNKQ | 281 | Q92954 | |
| TKETTTTNKQTSTDG | 286 | Q92954 | |
| TTNKQTSTDGKEKTT | 291 | Q92954 | |
| TSTDGKEKTTSAKET | 296 | Q92954 | |
| TATTTEKTTESKITA | 941 | Q92954 | |
| EKTTESKITATTTQV | 946 | Q92954 | |
| GTEKSTSVLSKSDSQ | 476 | Q8TEV9 | |
| TCQDTTSSKTTEGRK | 116 | Q9BY15 | |
| KTSTATSKTQTRLEG | 1636 | Q8IWZ3 | |
| ESTKLQTTGRKQSVS | 406 | Q8N957 | |
| TEEQTGKTFTKSSDT | 411 | Q13733 | |
| AESSSLTSVTTEETK | 1356 | Q9Y4G8 | |
| KSGSEAQTTKDSTSK | 111 | O43493 | |
| QETSTKSSETGSTKD | 841 | O60673 | |
| TTRTGEVVVTSKKDS | 1021 | Q9C0H9 | |
| VVELDQSKETSIKTS | 216 | Q9P2C4 | |
| ALETDSVSGVSKQSK | 721 | Q15022 | |
| GSLERKVKSTSSQTV | 1121 | O94964 | |
| STLISSDGVSKKSEV | 281 | Q6ZV73 | |
| DSDSTKTLTKQQSTT | 636 | Q9H582 | |
| EKNSQSLSTEVGKTT | 961 | Q86T82 | |
| ETSGSVKENSSQSKK | 21 | P51815 | |
| KDAVTTTVTGAKDSV | 116 | Q99541 | |
| EINKIISTTASKTET | 136 | O95292 | |
| VDGEITKTAKSSSSS | 46 | Q9H0M0 | |
| ESSEIKVETNISKTS | 526 | Q15849 | |
| LKAISEAQESVTKTT | 356 | Q6PJT7 | |
| STDNVSITKDSSKEV | 271 | O60293 | |
| NLEKKDVETTSSVSV | 16 | Q96RL1 | |
| SQKKDTSSSTVVSTQ | 86 | P31483 | |
| SKAVEIVTSTSAAKT | 781 | Q14966 | |
| RKVTVENTKTISDST | 6 | Q5T200 | |
| ITQVTASEKTKGATS | 576 | Q15061 | |
| SKIETIESTAKSTIS | 151 | Q49AA0 | |
| VQVTKKAVSTSSGVS | 4321 | Q5THJ4 | |
| SSTTSELTKKSEEVF | 1326 | Q14789 | |
| SSETGKVKTTSLTEK | 486 | Q5T7N2 | |
| VTATKDSTTSDVIKD | 36 | Q13459 | |
| EGITTSKQSTASKQT | 176 | P52179 | |
| EKIETSSVTTIKTFN | 811 | Q8NFW9 |